Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29579799 | 0.86 | TSHR (0.39) | TSHRALDH1A1TDP1 | |
| SCHEMBL3502068 | 0.83 | TSHR (0.40) | TSHRALDH1A1TDP1 | |
| SCHEMBL30131178 | 0.79 | ALDH1A1 (0.33) | TSHRALDH1A1 | |
| SCHEMBL3344974 | 0.74 | — | — | |
| SCHEMBL441470 | 0.71 | — | — | |
| SCHEMBL25278306 | 0.69 | — | — | |
| Hydrochloric Acid SCHEMBL2672014 | 0.69 | — | — | |
| SCHEMBL31438419 | 0.69 | ALDH1A1 (0.39) | TSHRALDH1A1TDP1TRPA1 | |
| SCHEMBL416818 | 0.67 | TRPA1 (0.50) | TSHRALDH1A1TDP1TRPA1HTT | |
| Propane SCHEMBL29212693 | 0.67 | ALDH1A1 (0.44) | ALDH1A1TDP1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025024565-A1 | CONTROLLED EXPANSION OF SORBENT POLYMER COMPOSITE ARTICLE | W. L. GORE & ASSOCIATES, INC. (US) | 2025-01-30 | — | — | WO | disclosed |
| US-20250032976-A1 | CONTROLLED EXPANSION OF SORBENT POLYMER COMPOSITE ARTICLE | GORE & ASS (US) | 2025-01-30 | — | — | US | disclosed |
| CN-117312159-A | Test data construction method and device and storage medium | 广发证券股份有限公司 | 2023-12-29 | — | — | CN | disclosed |
| CN-116637073-A | Active oxygen active nitrogen responsive nano composite micelle, preparation method thereof and nano medicine carrying micelle | 澳门大学 | 2023-08-25 | — | — | CN | disclosed |
| CN-116019596-A | Manufacturing method of liver and lung metastasis animal model for inducing pancreatic cancer through BOP | 南方医科大学深圳医院 | 2023-04-28 | — | — | CN | disclosed |
| CN-116019596-A | Manufacturing method of liver and lung metastasis animal model for inducing pancreatic cancer through BOP | 南方医科大学深圳医院 | 2023-04-28 | — | — | CN | disclosed |
| CN-113929903-B | Method for preparing terminal group high-fidelity polypeptide by NPCA polymerization initiated by protonated amino group | 中国科学技术大学 | 2022-10-28 | — | — | CN | disclosed |
| EP-2156188-B1 | INDUCTION OF DIFFERENTIAL STRESS RESISTANCE AND USES THEREOF | UNIV SOUTHERN CALIFORNIA (US) | 2021-05-05 | — | — | EP | disclosed |
| US-10821177-B2 | Induction of differential stress resistance and uses thereof | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2020-11-03 | — | — | US | disclosed |
| US-20160369237-A1 | METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY | ADVANCED CELL TECH INC (US) | 2016-12-22 | — | — | US | disclosed |
| US-20030100564-A1 | Novel methods for inhibiting angiogenesis | THE INSTITUTE FOR CANCER RESEARCH | 2003-05-29 | — | — | US | disclosed |
| WO-2003028715-A2 | METHODS USING 1, 2-DITHIOL-3-THIONES AND THEIR DERIVATIVES AND METABOLITES FOR INHIBITING ANGIOGENESIS | CEPHALON, INC. (US) | 2003-04-10 | — | — | WO | disclosed |
| EP-1229908-A1 | USE OF NSAIDs FOR THE TREATMENT OF PANCREATIC CANCER | ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE, Inc. (US) | 2002-08-14 | — | — | EP | disclosed |
| WO-2001035956-A1 | USE OF NSAIDs FOR THE TREATMENT OF PANCREATIC CANCER | ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE, INC. (US) | 2001-05-25 | — | — | WO | disclosed |
| US-6197796-B1 | Anticancer composition comprising a diaminotrifluoromethylpyridine derivative | ISHIHARA SANGYO KAISHA LTD. (JP) | 2001-03-06 | — | — | US | disclosed |
| US-6132708-A | Liver regeneration using pancreas cells | OREGON HEALTH SCIENCES UNIVERSITY (US) | 2000-10-17 | — | — | US | disclosed |
| EP-1021523-A1 | LIVER REGENERATION USING PANCREAS CELLS | OREGON HEALTH SCIENCES UNIVERSITY (US) | 2000-07-26 | — | — | EP | disclosed |
| EP-0971711-A1 | ANTICANCER COMPOSITION COMPRISING A DIAMINOTRIFLUOROMETHYLPYRIDINE DERIVATIVE | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2000-01-19 | — | — | EP | disclosed |
| WO-1999019461-A1 | LIVER REGENERATION USING PANCREAS CELLS | OREGON HEALTH SCIENCES UNIVERSITY (US) | 1999-04-22 | — | — | WO | disclosed |
| WO-1998037887-A1 | ANTICANCER COMPOSITION COMPRISING A DIAMINOTRIFLUOROMETHYLPYRIDINE DERIVATIVE | ISHIHARA SANGYO KAISHA LTD. (JP) | 1998-09-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030100564-A1 | Novel methods for inhibiting angiogenesis | TEK, TXNRD3, FLT4 | TSHR 810/4885ALDH1A1 127/4885TDP1 3280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.